Affordable Access

deepdyve-link
Publisher Website

Potential effects of postmenopausal labial agglutination on the urinary system.

Authors
  • Williams, Cheau1, 2, 3, 4
  • Robinson, Jermaine3
  • Leggio, Samantha4
  • 1 Colquitt Regional Medical Center, Philadelphia College of Osteopathic Medicine, Moultrie, GA, USA.
  • 2 Medical College of Georgia, USA. , (Georgia)
  • 3 2nd Year Resident at Colquitt Regional Medical Center, Georgia South Family Medicine Residency, Moultrie, GA, USA. , (Georgia)
  • 4 Philadelphia College of Osteopathic Medicine, USA.
Type
Published Article
Journal
Urology Case Reports
Publisher
Elsevier BV
Publication Date
May 01, 2021
Volume
36
Pages
101565–101565
Identifiers
DOI: 10.1016/j.eucr.2021.101565
PMID: 33489771
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Labial agglutination (LA) can affect prepubertal or postmenopausal women. LA commonly affects prepubertal girls, but the rate at which LA affects postmenopausal women is unknown, with only a few documented case reports. Symptoms of LA include vulvovaginal pain, dysuria, dyspareunia, and urinary incontinence/urinary symptoms. First-line treatment includes low dose estrogen cream and high dose topical steroid cream. If the creams fail, surgical lysis can be performed. The commonality between these age groups is chronic inflammation and low estrogen. It is important to keep in mind, especially in postmenopausal women, that LA can lead to urinary symptom side effects. © 2021 Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times